Clinical trial
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
NCT00547378 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
- Lead sponsor
- MedtronicNeuro
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- August 31, 2016
- Enrollment
- 571 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder, urinary incontinence, urgency-frequency